Vicente Plaza1, Jordi Giner1, Myriam Calle2, Paula Rytilä3, Carlos Campo4, Paula Ribó5, Antonio Valero5. 1. From the Department of Respiratory Medicine, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomédica Sant Pau, Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias, Universitat Autònoma de Barcelona, Barcelona, Spain. 2. Pulmonary Department, Hospital Clínico San Carlos, Department of Medicine, Faculty of Medicine, University Complutense of Madrid, Institute of Biomedical Research, Hospital Clínico San Carlos, Madrid, Spain. 3. Orion Corporation Orion Pharma, Espoo, Finl. 4. Orion Pharma, Madrid, Spain. 5. Servicio de Neumología y Alergia, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias, Barcelona, Spain.
Abstract
Background: Asthma guidelines recommend considering patient preferences for inhaler choice. However, few studies have assessed the impact of patient satisfaction with an inhaler on adherence and health outcomes. Objective: To assess the impact of patient satisfaction with an inhaler on adherence and health outcomes in asthma. Methods: In a cross-sectional, observational, multicenter study, 778 patients with moderate or severe asthma and who were treated with maintenance inhalers completed a number of scales and questionnaires: the Feeling of Satisfaction with Inhaler (FSI-10) questionnaire, the Treatment Satisfaction Questionnaire for Medication, the Test of Adherence to Inhalers (TAI), the Morisky-Green questionnaire, and the Asthma Control Test (ACT). Results: The study population was categorized according to a median FSI-10 score as high (49.4%) and low (50.6%) satisfaction with their inhaler. Logistic regression analysis showed that high specific satisfaction with an inhaler was associated with the younger age group (odds ratio [OR] 0.976 [95% confidence interval {CI} 0.965-0.987]); male gender (OR 1.725 [95% CI 1.187-2.507]); controlled asthma: ACT score ≥ 20 (OR 1.664 [95% CI 1.133-2.445]); high general satisfaction with treatment (OR 4.861 [95% CI 3.335-7.085]); high adherence to inhaler: TAI score ≥ 46 (OR 1.546 [95% CI 1.025-2.332]); nonsevere asthma (OR 1.056 [95% CI 0.648-1.721]); and no trouble with inhaler use (OR 0.401 [95% CI 0.174-0.922]). Conclusion: High patient satisfaction with an inhaler, irrespective of received medication, was related to adherence and asthma control. Our results pointed out the relevance of inhaler choice in inhaled therapy; these results could be useful for designing new strategies targeted to increase adherence in patients with asthma.
Background: Asthma guidelines recommend considering patient preferences for inhaler choice. However, few studies have assessed the impact of patient satisfaction with an inhaler on adherence and health outcomes. Objective: To assess the impact of patient satisfaction with an inhaler on adherence and health outcomes in asthma. Methods: In a cross-sectional, observational, multicenter study, 778 patients with moderate or severe asthma and who were treated with maintenance inhalers completed a number of scales and questionnaires: the Feeling of Satisfaction with Inhaler (FSI-10) questionnaire, the Treatment Satisfaction Questionnaire for Medication, the Test of Adherence to Inhalers (TAI), the Morisky-Green questionnaire, and the Asthma Control Test (ACT). Results: The study population was categorized according to a median FSI-10 score as high (49.4%) and low (50.6%) satisfaction with their inhaler. Logistic regression analysis showed that high specific satisfaction with an inhaler was associated with the younger age group (odds ratio [OR] 0.976 [95% confidence interval {CI} 0.965-0.987]); male gender (OR 1.725 [95% CI 1.187-2.507]); controlled asthma: ACT score ≥ 20 (OR 1.664 [95% CI 1.133-2.445]); high general satisfaction with treatment (OR 4.861 [95% CI 3.335-7.085]); high adherence to inhaler: TAI score ≥ 46 (OR 1.546 [95% CI 1.025-2.332]); nonsevere asthma (OR 1.056 [95% CI 0.648-1.721]); and no trouble with inhaler use (OR 0.401 [95% CI 0.174-0.922]). Conclusion: High patient satisfaction with an inhaler, irrespective of received medication, was related to adherence and asthma control. Our results pointed out the relevance of inhaler choice in inhaled therapy; these results could be useful for designing new strategies targeted to increase adherence in patients with asthma.
Authors: Vicente Plaza Moral; Soledad Alonso Mostaza; Cesáreo Alvarez Rodríguez; Antonio Gomez-Outes; Fernando Gómez Ruiz; Antolín López Vina; Jesús Molina París; Francisco Javier Pellegrini Belinchón; Javier Plaza Zamora; José Antonio Quintano Jiménez; Santiago Quirce Gancedo; José Sanz Ortega; Ramona Soler Vilarrasa; José Ramón Villa Asensi Journal: J Investig Allergol Clin Immunol Date: 2016 Impact factor: 4.333
Authors: Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft Journal: J Allergy Clin Immunol Date: 2004-01 Impact factor: 10.793
Authors: Vicente Plaza; Concepción Fernández-Rodríguez; Carlos Melero; Borja G Cosío; Luís Manuel Entrenas; Luis Pérez de Llano; Fernando Gutiérrez-Pereyra; Eduard Tarragona; Rosa Palomino; Antolín López-Viña Journal: J Aerosol Med Pulm Drug Deliv Date: 2015-07-31 Impact factor: 2.849
Authors: Mark L Levy; Will Carroll; José L Izquierdo Alonso; Claus Keller; Federico Lavorini; Lauri Lehtimäki Journal: Adv Ther Date: 2019-09-02 Impact factor: 3.845
Authors: June Hong Ahn; Jin Hong Chung; Kyeong-Cheol Shin; Hyun Jung Jin; Jong Geol Jang; Mi Suk Lee; Kwan Ho Lee Journal: Sci Rep Date: 2020-11-12 Impact factor: 4.379
Authors: Jong Geol Jang; Jin Hong Chung; Kyeong-Cheol Shin; Hyun Jung Jin; Kwan Ho Lee; June Hong Ahn Journal: Int J Chron Obstruct Pulmon Dis Date: 2021-04-19
Authors: Paula Ribó; Jesús Molina; Myriam Calle; Luis Maiz; Carlos Campo; Paula Rytilä; Vicente Plaza; Antonio Valero Journal: NPJ Prim Care Respir Med Date: 2020-07-31 Impact factor: 2.871
Authors: Francisco Javier Alvarez-Gutiérrez; Ana Gómez-Bastero Fernández; Juan Francisco Medina Gallardo; Carlos Campo Sien; Paula Rytilä; Julio Delgado Romero Journal: Patient Prefer Adherence Date: 2021-02-16 Impact factor: 2.711